Target Name: HCG4B
NCBI ID: G80868
Other Name(s): HCGIV-6 | HCGIV.5 | HLA complex group 4B | bPG309N1.1 | bQB90C11.3 | bCX67J3.3 | HCG4P6 | HCGIV-06

HCG: Potential Drug Targets and Applications in Research

Human chorionic gonadotropin (HCG) is a hormone produced by the placenta after fertilization occurs. It is a key indicator of pregnancy and is often used in home pregnancy tests. However, HCG also has been found to have a number of potential drug targets and is being studied as a potential treatment for a variety of conditions.

One of the most promising potential drug targets for HCG is its role in cancer. HCG has been shown to promote the growth and survival of cancer cells, and high levels of HCG have been found in various types of cancer. This has led to the idea that HCG could be a useful biomarker for cancer, as well as a potential drug target.

HCG has also been shown to play a role in the development and progression of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. It has been found that HCG levels increase in the brains of individuals with neurodegenerative diseases, and that these levels are associated with the severity of the disease. This suggests that HCG may be a useful target for neurodegenerative diseases.

Another potential drug target for HCG is its role in the treatment of infertility. HCG has been shown to reduce the amount of sperm produced by men, which can be a potential treatment for male infertility. Additionally, high levels of HCG have been found in the urine of women who are experiencing infertility, which suggests that HCG may also be a useful biomarker for infertility.

HCG has also been shown to play a role in the regulation of pain. It has been found that HCG levels increase in response to pain, and that these levels are associated with the severity of pain. This suggests that HCG may be a useful target for pain management.

In addition to its potential drug targets, HCG also has a number of potential applications in research. For example, it can be used as a potential marker for cancer recurrence after surgery, as well as for tracking the effectiveness of cancer treatments. Additionally, HCG can be used to study the effects of different treatments on the growth and development of cancer cells.

Overall, HCG is a promising drug target and has a wide range of potential applications in research and treatment. As more research is done on the role of HCG in cancer, neurodegenerative diseases, and infertility, it is likely that new treatments and therapies will be discovered that can help improve the health and well-being of individuals.

Protein Name: HLA Complex Group 4B

More Common Targets

HCG4P11 | HCG4P3 | HCG4P5 | HCG4P8 | HCG9 | HCGVIII-2 | HCK | HCLS1 | HCN1 | HCN2 | HCN3 | HCN4 | HCP5 | HCRT | HCRTR1 | HCRTR2 | HCST | HDAC1 | HDAC10 | HDAC11 | HDAC11-AS1 | HDAC1P1 | HDAC2 | HDAC2-AS2 | HDAC3 | HDAC4 | HDAC4-AS1 | HDAC5 | HDAC6 | HDAC7 | HDAC8 | HDAC9 | HDC | HDDC2 | HDDC3 | HDGF | HDGFL1 | HDGFL2 | HDGFL3 | HDHD2 | HDHD3 | HDHD5 | HDHD5-AS1 | HDLBP | HDX | Heat Shock Protein 27 (Hsp27) | Heat shock protein 70 | Heat shock protein 90 | HEAT2 | HEATR1 | HEATR3 | HEATR4 | HEATR5A | HEATR5B | HEATR6 | HEATR6-DT | HEATR9 | HEBP1 | HEBP2 | HECA | HECTD1 | HECTD2 | HECTD2-AS1 | HECTD3 | HECTD4 | HECW1 | HECW2 | Hedgehog Protein | HEG1 | HEIH | HELB | HELLS | HELQ | HELT | HELZ | HELZ2 | Heme Oxygenase (HO) | HEMGN | HEMK1 | Hemoglobin A-2 (HbA-2) | Hemoglobulin A (HbA) | HENMT1 | HEPACAM | HEPACAM2 | HEPH | HEPHL1 | HEPN1 | HER (erbB) | HERC1 | HERC2 | HERC2P10 | HERC2P2 | HERC2P3 | HERC2P4 | HERC2P5 | HERC2P7 | HERC2P8 | HERC2P9 | HERC3 | HERC4